文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

评估多学科数字疗法治疗髌股疼痛综合征患者安全性和有效性的前瞻性随机对照确证性临床研究方案

Study protocol for a prospective, randomized controlled confirmatory clinical investigation to evaluate the safety and efficacy of a multidisciplinary digital therapeutics in patients with patellofemoral pain syndrome.
PubMed 文献 · Trials · 2025-09-01

本研究为一项双臂对照试验,计划纳入216例髌股疼痛综合征患者,按1:1随机分为治疗组和对照组,治疗组使用结合结构化渐进式运动与认知行为疗法的数字疗法应用MORA Cure PFP,对照组使用教育材料自行锻炼,主要评价8周时常规疼痛强度评分的降低程度,并评估最严重疼痛、膝关节功能、抑郁和疼痛灾难化等指标。

要点

  • 拟纳入216例髌股疼痛综合征患者,按1:1随机分为数字疗法组和对照组。
  • 主要终点为8周时常规疼痛强度评分较基线的降低程度。
  • 次要评估包括最严重疼痛、膝关节功能、抑郁和疼痛灾难化水平。

核心结论

  • 本试验旨在确定治疗组在8周时常规疼痛强度评分的降低程度是否大于对照组。

研究设计与样本

  • 前瞻性、随机对照确证性临床研究,计划纳入216例诊断为髌股疼痛的患者,按1:1比例随机分配至治疗组和对照组。
  • 治疗组使用MORA Cure PFP应用,对照组使用教育材料进行自我指导锻炼。
  • 试验注册于ClinicalTrials.gov,注册号NCT06260865,注册日期2024年2月15日。

关键数值与推荐

  • 主要终点为8周时常规疼痛强度评分较基线的降低程度,治疗组与对照组进行比较。
  • 附加评估包括最严重疼痛、膝关节功能、抑郁和疼痛灾难化水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patellofemoral pain is a prevalent knee condition affecting up to 40% of individuals, especially females aged teens to 50 s. Standard treatments, including exercise therapy, often yield insufficient long-term results, partly due to low compliance and psychological factors like depression and catastrophizing of pain. A digital therapeutics "MORA Cure PFP," which combines structured progressive exercise and cognitive behavioral therapy via an app, offers a solution to overcome the limitations of conventional treatment for patellofemoral pain patients. METHODS: To evaluate the safety and efficacy of MORA Cure PFP, a two-arm controlled trial will enroll 216 patients diagnosed with patellofemoral pain randomly assigned in a 1:1 ratio to treatment and control groups. The treatment group will use the app, while the control group will perform self-guided exercises using educational materials. This trial aims to determine if the treatment group shows greater reduction in usual pain intensity scores at 8 weeks compared to the control group. Additional assessments include worst pain, knee function, depression, and pain catastrophizing levels. DISCUSSION: Key design elements of the clinical trial, such as control group selection, inclusion/exclusion criteria, number of patients, and primary endpoint, were designed with consideration for not only medical perspectives but also regulatory aspects of software as a medical device, including device approval and health technology assessment. TRIAL REGISTRATION: ClinicalTrials.gov., NCT06260865, registered 15th February 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Park TH, Yoon C, Park JH, et al. Study protocol for a prospective, randomized controlled confirmatory clinical investigation to evaluate the safety and efficacy of a multidisciplinary digital therapeutics in patients with patellofemoral pain syndrome. Trials. 2025. PMID: 40890852. doi:10.1186/s13063-025-09030-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。